Journals / Endoskopi / 2013 / Cilt: 21 - Sayı: 1

The success of combination treatment in the management of a patient with hereditary hemorrhagic telangiectasia

Herediter hemorajik telenjektazili bir vakanın, argon plazma koagülasyonu ve destek tedavisi kombinasyonuyla başarılı yönetimi

Journal
Endoskopi
Pages
31–33
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The rapid healing ob- served with this treatment supports that combination treatment is effective in angiodysplastic lesions associated with hereditary hemorrhagic telangi- ectasia

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome), a vascular disorder with autosomal dominant transmission, has a variety of clinical manifestations.
📊
Key Findings & Data:In this case, we monitored a 65-year-old female who admitted to our hospital with gastrointestinal bleeding.
💡
Conclusion & Impact:The rapid healing ob- served with this treatment supports that combination treatment is effective in angiodysplastic lesions associated with hereditary hemorrhagic telangi- ectasia
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome), a vascular disorder with autosomal dominant transmission, has a variety of clinical manifestations. In this case, we monitored a 65-year-old female who admitted to our hospital with gastrointestinal bleeding. Her history revealed repeated myocardial infarction (4 times). We diagnosed multiple angiodys- plastic lesions with endoscopic examination. We evaluated the success of combination treatment with argon plasma coagulation and supportive ap- proach at the time of diagnosis. argon plasma coagulation and bipolar co- agulation methods have been reported as the preferred treatments in several studies. Therefore, we preferred the combination of argon plasma coagula- tion and conservative treatment methods in our case. The rapid healing ob- served with this treatment supports that combination treatment is effective in angiodysplastic lesions associated with hereditary hemorrhagic telangi- ectasia

Özet

Herediter hemorajik telenjiektazi, otozomal dominant geçişli, birçok klinik bulguyla karakterize, anormal vasküler formasyonla ilişkili nadir gözlenen bir hastalıktır. Biz bu vakada, gastrointestinal sistemin multiple bölgesinde (özofagus, mide korpus ve antrumu, duodenum) anjiodisplazik lezyonlarla seyreden, öyküsünde dört kez geçirilmiş miyokard infarktüsü bulunan, acil servise melena ile başvuran 65 yaşındaki olguya tanı anında yapılan argon plazma koagülasyon ve supportif yaklaşım kombinasyonun tedavi başarısını gözlemledik. Tanı anında uygulanan argon plazma koagülasyon ve bipolar koagülasyon yöntemleri bir çok çalışmada tercih edilen yöntemler olmuştur. Bu nedenle biz bu olgumuzda argon plazma koagülasyon yöntemini ve çalış- malarda etkisi kanıtlanmış konservatif tedavi kombinasyonunu tercih ettik. Bizim vakamızın argon plazma koagülasyon yöntemiyle beraber destek teda- visine verdiği hızlı cevap argon plazma koagülasyonun herediter hemorajik telenjiektaziye bağlı anjiodisplazik lezyonlarda seçkin tedavi yöntemi olduğu görüşünü desteklemektedir

🔖

Cite This Article

KAYATAŞ, K., ŞENATEŞ, E., YEŞİL, A., ŞENATEŞ, B. E., GÜÇLÜTÜRK, A., DEMİRTUNÇ, R. (2022). The success of combination treatment in the management of a patient with hereditary hemorrhagic telangiectasia. Endoskopi, Cilt: 21 - Sayı: 1, 31–33. https://ajindex.com/articles/501162

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Govani FS, Shovlin CL. Hereditary haemorrhagic telangiectasia a clinical and scientific review. Eur J Hum Genet 2009;17:860-71
  2. Shovlin CL. Hereditary haemorrhagic telangiectasia:pathophysiology, diagnosis and treatment. Blood Rev 2010;24:203-19
  3. Fiorella ML, Lillo L, Fiorella R. Diode laser in the treatment of epistaxis in patients with hereditary haemorrhagic telangiectasia. Acta Otorhinolaryngol Ital 2012;32:164-9
  4. Candelli M, Pompili M, Suppressa P, et al. Liver involvement in hereditary hemorrhagic telangiectasia: can breath test unmask impaired hepatic firstpass effect? Intern Emerg Med 2012;7:323-9
  5. Olitsky SE. Hereditary hemorrhagic telangiectasia: diagnosis and management. Am Fam Physician 2010;82:785-90
  6. Hsi DH, Ryan GF, Hellems SO, et al. Large aneurysms of the ascending aorta and major coronary arteries in a patient with hereditary hemorrhagic telangiectasia. Mayo Clin Proc 2003;78:774-6
  7. Zarrabeitia R, Albiñana V, Salcedo M, et al. A review on clinical management and pharmacological therapy on hereditary haemorrhagic telangiectasia (HHT). Curr Vasc Pharmacol 2010;8:473-81
  8. Johnston CM, Schoenfeld LP, Mysore JV, Dubois A. Endoscopic spray cryotherapy: a new technique for mucosal ablation in the esophagus. Gastrointest Endosc 1999;50:86-92
  9. Pavey DA, Craig PI. Endoscopic therapy for upper-GI vascular ectasias. Gastrointest Endosc 2004;59:233-8
  10. Kantsevoy SV, Cruz-Correa MR, Vaughn CA, et al. Endoscopic cryotherapy for the treatment of bleeding mucosal vascular lesions of the GI tract: a pilot study. Gastrointest Endosc 2003;57:403-6
  11. Lewis BS, Salomon P, Rivera-MacMurray S, et al. Does hormonal therapy have any benefit for bleeding angiodysplasia? J Clin Gastroenterol 1992;15:99-103
  12. Barkin JS, Ross BS. Medical therapy for chronic gastrointestinal bleeding of obscure origin. Am J Gastroenterol 1998;93:1250-4
  13. Hodgson H. Hormonal therapy for gastrointestinal angiodysplasia. Lancet 2002;359:1630-1
  14. Plessevaux H, Coremans G, Rutgeert P, et al. Octreotide in the treatment of bleeding gastrointestinal vascular malformations. Gastroenterology 1996;110:A353
  15. Orsi P, Guatti-Zuliani C, Okolicsanyi L. Long-acting octreotide is effective in controlling rebleeding angiodysplasia of the gastrointestinal tract. Dig Liver Dis 2001;33:330-4
  16. Nardone G, Rocco A, Balzano T, Budillon G. The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Aliment P